Figure 1.
Swimmer plot outlining the timeline for clinical response in each patient’s best-response organ. These courses may be cross referenced against details in Table 2, which shows cotherapies and active organs at the time of LD IL-2 start (time 0 on x-axis). CsA, cyclosporine; IPA, invasive pulmonary aspergillosis; ITP, immune thrombocytopenia; MMF, mycophenolate mofetil; MOF, multiorgan failure; PsA, Pseudomonas; PNA, pneumonia; Tacro, tacrolimus; Vedo, vedolizumab.